Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment. Vellas C, Kamar N, Izopet J. J Infect 2022 Jul 22. pii: S0163-4453(22)00422.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vellas C, Kamar N, Izopet J. Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment. J Infect 2022 Jul 22. pii: S0163-4453(22)00422.
PMID: 35878684